Ad Deum Funds, LLC – Trademark Portfolio
Entity Type: 16
Ad Deum Funds, LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include KYRIOS, VOLLAND, AD DEUM FUNDS, and WIZARD OF OPS. The owner is based in South Riding, VA.
25218 Ulysses Street
South Riding, VA 20152
Showing of trademarks Trademarks
Trademark Classifications
Ad Deum Funds, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Ad Deum Funds, LLC have?
Ad Deum Funds, LLC has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.
What trademark classes does Ad Deum Funds, LLC file in?
Ad Deum Funds, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Ad Deum Funds, LLC's most well-known trademarks?
Ad Deum Funds, LLC's registered trademark portfolio includes well-known marks such as KYRIOS, VOLLAND, AD DEUM FUNDS, and WIZARD OF OPS. These are among 4 currently registered trademarks in the portfolio.
What is Ad Deum Funds, LLC's trademark registration success rate?
Ad Deum Funds, LLC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.